Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma

BACKGROUND: The response of advanced clear cell renal cell carcinoma (ccRCC) to immunotherapy is still not durable, suggesting that the immune landscape of ccRCC still needs to be refined, especially as some molecules that have synergistic effects with immune checkpoint genes need to be explored. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhi-Cheng, Liu, Yi-Fu, Xi, Ping, Nie, Ye-Chen, Sun, Ting, Gong, Bin-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837903/
https://www.ncbi.nlm.nih.gov/pubmed/36635779
http://dx.doi.org/10.1186/s41065-023-00262-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837903/
https://www.ncbi.nlm.nih.gov/pubmed/36635779
http://dx.doi.org/10.1186/s41065-023-00262-3

Ejemplares similares